Cannabidiol, or CBD, is popping up everywhere, from creams to coffee to prescriptions. CBD is one of the key compounds in cannabis plants, though it doesn’t cause marijuana’s characteristic high. It’s being touted as a treatment for all kinds of ailments, but the evidence for some uses is thin.

Meanwhile, CBD is already a $1 billion industry, and some on Wall Street think it could reach $16 billion, aided in part by a recent change in US law that made some CBD legal.

The CBD boom on Wall Street

Food, Science, and Medicine:

Startups, venture capital and private equity

Policy

Lists